Is Age an Independent Risk Factor for Chemically Induced Acute Myelogenous Leukemia in Children?

Author： Pyatt David W. Aylward Lesa L. Hays Sean M.

ISSN： 1521-6950

Source： Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol.10, Iss.5, 2007-07, pp. : 379-400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiangiogenic Therapy in Acute Myelogenous Leukemia: Targeting of Vascular Endothelial Growth Factor and Interleukin 8 as Possible Antileukemic Strategies

Current Cancer Drug Targets, Vol. 5, Iss. 4, 2005-06 ,pp. : 229-248

Bentham Science Publishers

Access to resources Recommend Favorite

The clinically relevant pharmacogenomic changes in acute myelogenous leukemia

By Emadi Ashkan Karp Judith E

Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. : 1257-1269

Future Medicine

Access to resources Recommend Favorite

Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia

By Evangelisti Camilla

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 921-936

Informa Healthcare

Access to resources Recommend Favorite

Targeting FLT3 Kinase in Acute Myelogenous Leukemia: Progress, Perils, and Prospects

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 255-271

Bentham Science Publishers

Access to resources Recommend Favorite

FLT3 and Acute Myelogenous Leukemia: Biology, Clinical Significance and Therapeutic Applications

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3449-3457

Bentham Science Publishers

Access to resources Recommend Favorite